Microbix specializes in developing proprietary biological technologies, which have lead to the development of a pipeline of products in three areas; Biotherapeutics, vaccines and non-therapeutic biologics. Microbix was founded in 1988 and created Microbix Virology (Since renamed Microbix Core Base Business) which was to commercialize, develop and manufacture infectious disease antigens for medical diagnostic tests for major multinational manufacturers.